Shares of Mead Johnson Nutrition CO (NYSE:MJN) have received a consensus recommendation of “Hold” from the fifteen ratings firms that are covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation and thirteen have issued a hold recommendation on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $82.50.
Several analysts recently weighed in on MJN shares. Canaccord Genuity restated a “speculative buy” rating on shares of Mead Johnson Nutrition CO in a report on Wednesday, July 5th. BMO Capital Markets reaffirmed a “hold” rating and issued a $90.00 price objective on shares of Mead Johnson Nutrition CO in a research report on Thursday, June 15th. Finally, BidaskClub raised Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a research report on Wednesday, June 14th.
Mead Johnson Nutrition CO (MJN) traded down 0.01% during mid-day trading on Friday, reaching $89.98. 11,923,467 shares of the company traded hands. Mead Johnson Nutrition CO has a 12-month low of $69.25 and a 12-month high of $94.40. The company’s 50 day moving average price is $89.62 and its 200 day moving average price is $84.34.
COPYRIGHT VIOLATION WARNING: “Mead Johnson Nutrition CO (MJN) Receives $82.50 Consensus Target Price from Brokerages” was originally posted by Transcript Daily and is the property of of Transcript Daily. If you are viewing this report on another domain, it was stolen and republished in violation of US & international copyright and trademark laws. The correct version of this report can be accessed at https://transcriptdaily.com/2017/09/19/mead-johnson-nutrition-co-mjn-receives-82-50-consensus-target-price-from-brokerages.html.
Several large investors have recently made changes to their positions in the company. Bahl & Gaynor Inc. purchased a new position in shares of Mead Johnson Nutrition CO in the second quarter worth about $296,000. Achmea Investment Management B.V. purchased a new position in shares of Mead Johnson Nutrition CO in the first quarter worth about $262,000. Bank of Nova Scotia raised its stake in shares of Mead Johnson Nutrition CO by 926.3% in the first quarter. Bank of Nova Scotia now owns 42,039 shares of the company’s stock worth $3,745,000 after purchasing an additional 37,943 shares during the last quarter. Tyrus Capital S.A.M. purchased a new position in shares of Mead Johnson Nutrition CO in the first quarter worth about $50,852,000. Finally, Driehaus Capital Management LLC purchased a new position in shares of Mead Johnson Nutrition CO in the first quarter worth about $17,048,000. Hedge funds and other institutional investors own 88.40% of the company’s stock.
About Mead Johnson Nutrition CO
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.